Author

Jane Andrews 1

1 Royal Adelaide Hospital,Adelaide,Australia

ADALIMUMAB AND INFLIXIMAB CLEARANCE IN NEONATES (ERA STUDY)

Mette Julsgaard, Lisbet Ambrosius Christensen, Peter R. Gibson, Richard Blair Gearry, Jan Fallingborg, jens kjeldsen, Signe Wildt, Lise Svenningsen, William Connell, Christian Lodberg Hvas, Miles P. Sparrow, Alissa Walsh, Susan J. Connor, Graham Radford-Smith, Ian Lawrance, Jane Andrews, Katie Ellard, Ourania Rosella, Ann

DIFFERENT SUBTYPES OF PATIENTS WITH IRRITABLE BOWEL SYNDROME HAVE DISTINCT ALTERATIONS IN THE GUANYLATE CYCLASE-C/CYCLIC GMP PATHWAY

Andrea M. Harrington, Richard L. Young, Caroline B. Kurtz, Immaculada Silos-Santiago, Quoc Nam Nguyen, Jane Andrews, Stuart M. Brierley

EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

William J. Sandborn, Tadakazu Hisamatsu, Kathleen Weisel, Susana Gonzalez, Mary Ellen Frustaci, Zijiang Yang, Jewel Johanns, Matthew Germinaro, Brian Feagan, Aniita Afzali, Walter Reinisch, Jane Andrews, Omoniyi J. Adedokun, Chenglong Han

EFFICACY OUTCOMES BY SYMPTOM-BASED RESPONSE STATUS AFTER INDUCTION: WEEK-48 RESULTS FROM THE GALAXI 1 TRIAL OF GUSELKUMAB IN CROHN’S DISEASE

Julian Panés, Anita Afzali, David T. Rubin, Bruce E. Sands, Walter Reinisch, Geert R. D'Haens, Mario Gomez, Natalie Terry, Aparna Sahoo, Mary Ellen Frustaci, Zijiang Yang, William J. Sandborn, Remo Panaccione, Tadakazu Hisumatsu, Silvio Danese, Jane Andrews, Brian G. Feagan

FAECAL CALPROTECTIN HELPS DETERMINE THE NEED FOR POST-OPERATIVE COLONOSCOPY IN CROHN’S DISEASE. PROSPECTIVE LONGITUDINAL ENDOSCOPIC VALIDATION. RESULTS FROM THE POCER STUDY.

Emily Wright, Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Steven Leach, Alexandra Gorelik, Lani Prideaux, Danny Liew, Ian Lawrence, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Pe

GROUP-BASED TRAJECTORY ANALYSIS OF WEIGHT CHANGE IN AN INFLIXIMAB-TREATED COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

Zhi Xin Tan, Patricia Kaazan, Jane Andrews, Jana Bednarz, Prakashkumar Maiyani, Carolyn McIvor

HEALTH-RELATED QUALITY OF LIFE WITH GUSELKUMAB INDUCTION AND MAINTENANCE THERAPY AS MEASURED BY PROMIS-29: RESULTS THROUGH WEEK 48 OF PHASE 2 GALAXI 1 STUDY

Geert R. D'Haens, Bruce E. Sands, Remo Panaccione, Chenglong Han, Susana Gonzalez, Kathleen Weisel, Mary Ellen Frustuaci, Zijiang Yang, Aparna Sahoo, Anita Afzali, Jane Andrews, Silvio Danese, Tadakazu Hisamatsu, Brian G. Feagan, Julian Panés, Walter Reinisch, William J. Sandborn, David T. Rubin

IMMUNE ACTIVATION IS ASSOCIATED WITH SYMPTOM FLARE IN DIARRHOEA PREDOMINANT IRRITABLE BOWEL SYNDROME

Melissa Moretta, Jane Andrews

INTEGTRATING PSYCHOLOGICAL SUPPORT INTO ROUTINE CARE FOR  PEOPLE WITH INFLAMMATORY BOWEL DISEASE.

Taryn Lores, Charlotte Goess, Chris Hrycek, Rachel Grafton, Julie Hughes, Lucy Cronin, Antonina Mikocka-Walus, Anna Chur-Hansen, Anne LJ Burke, Kathryn L Collins, Jane Andrews

OPTIMISING POST-OPERATIVE CROHN’S DISEASE MANAGEMENT: BEST DRUG THERAPY ALONE VERSUS ENDOSCOPIC MONITORING WITH TREATMENT STEP-UP. THE POCER STUDY

Peter De Cruz, Amy Hamilton, Kathryn Ritchie, Soula Krejany, Alexandra Gorelik, Danny Liew, Lani Prideaux, Ian Lawrance, Miles P. Sparrow, Timothy Florin, Peter R. Gibson, Henry Debinski, Richard Blair Gearry, Finlay A. Macrae, Rupert W Leong, Ian Kronborg, Warwick Selby, Michael Patrick Johnston, Rodney Woods, Ross Elli

Item 1 - 10 / 22
1
2 3